Skip to content

WHWK WHWK Change in AP

Change in AP at other companies

Eli Lilly logo
Eli LillyLLY
$2.55B+290%
Pfizer logo
PfizerPFE
-$117.25M+54.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$107.7M+150%
Gilead Sciences logo
Gilead SciencesGILD
-$67M+36.2%
AbbVie logo
AbbVieABBV
-$1.59B-129%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$3.05M+11.8%

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's change in AP?
WHWK (WHWK) reported change in AP of -$3.49M in Q1 2026.
How has WHWK's change in AP changed year-over-year?
WHWK's change in AP decreased by 458.4% year-over-year, from $975K to -$3.49M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.